InceptionR’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-7,855
Closed -$628K 636
2025
Q3
$628K Buy
+7,855
New +$670K 0.15% 251
2025
Q2
Sell
-8,043
Closed -$754K 680
2025
Q1
$754K Sell
8,043
-5,615
-41% -$503K 0.23% 166
2024
Q4
$1.24M Sell
13,658
-753
-5% -$71.9K 0.28% 108
2024
Q3
$1.5M Buy
+14,411
New +$1.47M 0.37% 46
2024
Q2
Sell
-4,313
Closed -$388K 620
2024
Q1
$388K Buy
+4,313
New +$365K 0.1% 355
2023
Q4
Sell
-4,564
Closed -$325K 381
2023
Q3
$325K Buy
+4,564
New +$341K 0.18% 242
2023
Q2
Sell
-3,736
Closed -$281K 442
2023
Q1
$281K Sell
3,736
-10,778
-74% -$801K 0.09% 351
2022
Q4
$1.14M Buy
+14,514
New +$1.09M 0.6% 13

Other funds holding CL

InceptionR's CL Position: Q4 2025 in Review

InceptionR sold out of Colgate-Palmolive (CL) in Q4 2025, closing a stake of 7,855 shares — an estimated $628K sold.

InceptionR first reported a position in CL in Q4 2022 and held it in 8 quarters. The position peaked at $1.5M in Q3 2024. 1,892 funds tracked by Wall St. Rank hold CL as of Q4 2025.

  • InceptionR reported no remaining Colgate-Palmolive position as of Q4 2025 after selling out during the quarter.
  • InceptionR sold 7,855 Colgate-Palmolive shares in Q4 2025, an estimated $628K.
  • InceptionR first reported a position in Colgate-Palmolive in Q4 2022 and held it in 8 quarters.
  • InceptionR's Colgate-Palmolive position peaked at $1.5M in Q3 2024.
  • 1,892 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2025.

Based on InceptionR's 13F filing for Q4 2025, filed 11 Feb 2026.